{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:54:09Z","timestamp":1792792449121,"version":"4.5.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immune control of human cytomegalovirus (HCMV) replication is critical in bone marrow and solid organ transplant recipients, where uncontrolled replication can lead to high mortality. Current commercial immune monitoring tools have several limitations, such as a lack of appropriate test cutoff values and the inability to characterise antigen-specific T cells. The main aim of our study was to develop a new interferon-\u03b3 (IFN-\u03b3) release assay (IGRA), easy to use, to quantify and characterise the HCMV-specific T-cell response (pp65-IGRA). Secondary analyses included an evaluation of the performance of pp65-IGRA to assess whether its specificity and sensitivity were equal to or greater than those of the intracellular cytokine staining (ICS) and enzyme-linked immunospot (ELISpot) assays. In the study, 76 immunocompetent donors and nine solid organ transplant recipients were enrolled. Blood samples or peripheral blood mononuclear cells were stimulated with HCMV pp65-recombinant protein or with a complete pool of overlapping pp65 peptides. IFN-\u03b3 production was analysed by enzyme-linked immunoassay, ELISpot assays, and flow cytometry. For each assay, appropriate cutoff values were calculated. Our data demonstrate the suitability of pp65-IGRA for the quantification of HCMV-specific CD4<jats:sup>+<\/jats:sup> T-cell responses and may support its use in routine clinical practice to improve the management of immunocompromised patients.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1553305","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:11:10Z","timestamp":1747282270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Performance of new pp65-IGRA for the quantification of HCMV-specific CD4+ T-cell response in healthy subjects and in solid organ transplant recipients"],"prefix":"10.3389","volume":"16","author":[{"given":"Dalila","family":"Mele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zavaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bergami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Gregorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica Federica","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuditta","family":"Comolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cassaniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Lilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Baldanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/rmv.v26.2","article-title":"Cytomegalovirus latency and reactivation: recent insights into an age old problem","volume":"26","author":"Dupont","year":"2016","journal-title":"Rev Med Virol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1128\/CMR.00034-08","article-title":"Immunobiology of human cytomegalovirus: from bench to bedside","volume":"22","author":"Crough","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00582-z","article-title":"). Pathogenesis of human cytomegalovirus in the immunocompromised host","volume":"19","author":"Griffiths","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"102185","DOI":"10.1016\/j.coi.2022.102185","article-title":"T cell immunity to cytomegalovirus infection. Curr","volume":"77","author":"Zangger","year":"2022","journal-title":"Opin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.08.002","article-title":"Reconstitution of human cytomegalovirus-specific CD4+ T cells is critical for control of virus reactivation in hematopoietic stem cell transplant recipients but does not prevent organ infection","volume":"21","author":"Gabanti","year":"2015","journal-title":"Biol Blood Marrow. Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-1986-z","article-title":"The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients","volume":"72","author":"Ci\u00e1urriz","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02128-16","article-title":"Human cytomegalovirus (HCMV)-specific CD4+ T cells are polyfunctional and can respond to HCMV-infected dendritic cells in vitro","volume":"91","author":"Jackson","year":"2017","journal-title":"J Virol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148841","article-title":"CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis","volume":"14","author":"Lauruschkat","year":"2023","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological Malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e13512","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705825","article-title":"Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT","volume":"40","author":"Avetisyan","year":"2007","journal-title":"Bone Marrow Transpl"},{"key":"B12","doi-asserted-by":"publisher","first-page":"ofw107","DOI":"10.1093\/ofid\/ofw107","article-title":"Efficacy and safety of a preemptive antiviral therapy strategy based on combined virological and immunological monitoring for active cytomegalovirus infection in allogeneic stem cell transplant recipients","volume":"3","author":"Navarro","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-878918","article-title":"Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation","volume":"133","author":"Camargo","year":"2019","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"104734","DOI":"10.1016\/j.jcv.2021.104734","article-title":"Early T cell reconstitution and cytokine profile may help to guide a personalized management of human cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation","volume":"135","author":"Gabanti","year":"2021","journal-title":"J Clin Virol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041648","article-title":"Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Lilleri","year":"2012","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2006.00199.x","article-title":"Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV","volume":"9","author":"Walker","year":"2007","journal-title":"Transplant Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074744","article-title":"Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV\u00ae assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications","volume":"8","author":"Tey","year":"2013","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/infdis\/jiy592","article-title":"The ability of a cytomegalovirus ELISPOT assay to predict outcome of low-level CMV reactivation in hematopoietic cell transplant recipients","volume":"219","author":"El Haddad","year":"2019","journal-title":"J Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1038\/s41598-020-64133-x","article-title":"Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact","volume":"10","author":"Valle-Arroyo","year":"2020","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M809456200","article-title":"Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cells","volume":"284","author":"Zhang","year":"2009","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"ofaa547","DOI":"10.1093\/ofid\/ofaa547","article-title":"T-cell immune surveillance in allogenic stem cell transplant recipients: are whole blood-based assays ready to challenge ELISPOT","volume":"8","author":"Lauruschkat","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.04.008","article-title":"Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host","volume":"136","author":"Zelini","year":"2010","journal-title":"Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/cells13161325","article-title":"Immune control of human cytomegalovirus (HCMV) infection in HCMV-seropositive solid organ transplant recipients: the predictive role of different immunological assays","volume":"13","author":"Zavaglio","year":"2024","journal-title":"Cells"},{"key":"B24","article-title":"Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients","volume":"36","author":"Lilleri","year":"2013","journal-title":"New Microbiol"},{"key":"B25","article-title":"Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli","author":"Gabanti","year":"2016","journal-title":"New Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4236503","DOI":"10.1155\/2019\/4236503","article-title":"Evaluation of EBV- and HCMV-specific T cell responses in systemic lupus erythematosus (SLE) patients using a normalized enzyme-linked immunospot (ELISPOT) assay","author":"Cassaniti","year":"2019","journal-title":"J Immunol Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.ede.0000147512.81966.ba","article-title":"Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples","volume":"16","author":"Schisterman","year":"2005","journal-title":"Epidemiology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e13666","DOI":"10.1111\/ctr.v33.10","article-title":"Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies","volume":"33","author":"Girmenia","year":"2019","journal-title":"Clin Transplant"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13786","article-title":"QuantiFERON-cytomegalovirus to predict clinically significant cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Thompson","year":"2022","journal-title":"Transplant Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1210","article-title":"Cytomegalovirus (CMV) cell-mediated immunity and CMV infection after allogeneic hematopoietic cell transplantation: the REACT study","volume":"71","author":"Chemaly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14347","article-title":"An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation","volume":"17","author":"Kumar","year":"2017","journal-title":"Am J Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/vaccines9020088","article-title":"Comparison of three cellular assays to predict the course of CMV infection in liver transplant recipients","volume":"9","author":"Gliga","year":"2021","journal-title":"Vaccines"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2018.06.009","article-title":"T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients","volume":"105","author":"Gliga","year":"2018","journal-title":"J Clin Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2001191","article-title":"TLR-4 Agonist Induces IFN-\u03b3 Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K Pathway","volume":"207","author":"Gajanayaka","year":"2021","journal-title":"J Immunol (Baltimore Md.: 1950)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cyto.2014.02.001","article-title":"Human monocytes produce interferon-gamma upon stimulation with LPS","volume":"67","author":"Kraaij","year":"2014","journal-title":"Cytokine"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/13.6.785","article-title":"Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response","volume":"13","author":"Zhu","year":"2001","journal-title":"Int Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0189488","DOI":"10.1371\/journal.pone.0189488","article-title":"Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients","volume":"12","author":"Lee","year":"2017","journal-title":"PloS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1553305\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:11:12Z","timestamp":1747282272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1553305\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2025.1553305"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1553305","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"article-number":"1553305"}}